Longcheng Shang

1.2k total citations · 1 hit paper
21 papers, 961 citations indexed

About

Longcheng Shang is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Longcheng Shang has authored 21 papers receiving a total of 961 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Epidemiology and 6 papers in Hepatology. Recurrent topics in Longcheng Shang's work include Liver Disease Diagnosis and Treatment (5 papers), MicroRNA in disease regulation (4 papers) and Liver physiology and pathology (3 papers). Longcheng Shang is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), MicroRNA in disease regulation (4 papers) and Liver physiology and pathology (3 papers). Longcheng Shang collaborates with scholars based in China and Israel. Longcheng Shang's co-authors include Yuan Zhou, Haozhen Ren, Xiaolei Shi, Jianfei Huang, Jun Li, Bo Dai, Faji Yang, Xiaolei Shi, Yuheng Zhang and Wei Zhu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Scientific Reports and Free Radical Biology and Medicine.

In The Last Decade

Longcheng Shang

21 papers receiving 958 citations

Hit Papers

Hepatocellular carcinoma-derived exosomal miRNA-21 contri... 2018 2026 2020 2023 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts
    2018 370 citations Yuan Zhou, Haozhen Ren et al. Journal of Experimental & Clinical Cancer Research profile →

Peers

Longcheng Shang
Mitsuhiko Abe Japan
Kate Huang China
Alexander R. Terry United States
Xing Sun China
Yuyu Yang China
Kun Wu China
Jian Kong China
Qinyi Zhou China
Sijun Yang China
Mitsuhiko Abe Japan
Longcheng Shang
Citations per year, relative to Longcheng Shang Longcheng Shang (= 1×) peers Mitsuhiko Abe

Countries citing papers authored by Longcheng Shang

Since Specialization
Citations

This map shows the geographic impact of Longcheng Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longcheng Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longcheng Shang more than expected).

Fields of papers citing papers by Longcheng Shang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Longcheng Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longcheng Shang. The network helps show where Longcheng Shang may publish in the future.

Co-authorship network of co-authors of Longcheng Shang

This figure shows the co-authorship network connecting the top 25 collaborators of Longcheng Shang. A scholar is included among the top collaborators of Longcheng Shang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Longcheng Shang. Longcheng Shang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Wei, Wei‐Jun Yang, Jin Zhou, et al.. (2025). EHF promotes liver cancer progression by meditating IL-6 secretion through transcription regulation of KDM2B in TAMs. PubMed. 129. 111670–111670. 2 indexed citations
2.
Li, Yan, et al.. (2024). Exploration on the effect of anserine on the alleviation of DVT and its molecular mechanism. Frontiers in Pharmacology. 15. 1402758–1402758. 2 indexed citations
3.
Li, Yan, et al.. (2024). HSYA ameliorates venous thromboembolism by depleting the formation of TLR4/NF-κB pathway-dependent neutrophil extracellular traps. International Immunopharmacology. 143(Pt 3). 113534–113534. 4 indexed citations
4.
Yu, Chao, Xinyi Zhang, Min Wang, et al.. (2023). Afatinib combined with anti-PD1 enhances immunotherapy of hepatocellular carcinoma via ERBB2/STAT3/PD-L1 signaling. Frontiers in Oncology. 13. 1198118–1198118. 8 indexed citations
5.
Shang, Longcheng, et al.. (2023). MSCs Ameliorate Hepatic IR Injury by Modulating Phenotypic Transformation of Kupffer Cells Through Drp-1 Dependent Mitochondrial Dynamics. Stem Cell Reviews and Reports. 19(6). 1965–1980. 9 indexed citations
6.
Yu, Chao, et al.. (2023). The role of tumor‐associated macrophages in hepatocellular carcinoma progression: A narrative review. Cancer Medicine. 12(24). 22109–22129. 16 indexed citations
7.
Wu, Xiaoyan, Wenhui Dong, Ming Kong, et al.. (2021). Down-Regulation of CXXC5 De-Represses MYCL1 to Promote Hepatic Stellate Cell Activation. Frontiers in Cell and Developmental Biology. 9. 680344–680344. 21 indexed citations
8.
Fan, Zhiwen, Ming Kong, Xiulian Miao, et al.. (2021). An E2F5-TFDP1-BRG1 Complex Mediates Transcriptional Activation of MYCN in Hepatocytes. Frontiers in Cell and Developmental Biology. 9. 742319–742319. 13 indexed citations
9.
Wu, Xiaoyan, Wenhui Dong, Tianyi Zhang, et al.. (2021). Epiregulin (EREG) and Myocardin Related Transcription Factor A (MRTF-A) Form a Feedforward Loop to Drive Hepatic Stellate Cell Activation. Frontiers in Cell and Developmental Biology. 8. 591246–591246. 25 indexed citations
10.
Shang, Longcheng, Haozhen Ren, Shuai Wang, et al.. (2021). SS‐31 Protects Liver from Ischemia‐Reperfusion Injury via Modulating Macrophage Polarization. Oxidative Medicine and Cellular Longevity. 2021(1). 6662156–6662156. 33 indexed citations
11.
Cai, Jing, Meng Zhang, Yutong Liu, et al.. (2020). Iron accumulation in macrophages promotes the formation of foam cells and development of atherosclerosis. Cell & Bioscience. 10(1). 137–137. 46 indexed citations
12.
Li, Huihui, Yutong Liu, Longcheng Shang, et al.. (2019). Iron regulatory protein 2 modulates the switch from aerobic glycolysis to oxidative phosphorylation in mouse embryonic fibroblasts. Proceedings of the National Academy of Sciences. 116(20). 9871–9876. 43 indexed citations
13.
Liu, Yang, Haozhen Ren, Yuan Zhou, et al.. (2019). The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming. Journal of Experimental & Clinical Cancer Research. 38(1). 228–228. 68 indexed citations
14.
15.
Yang, Faji, Yuheng Zhang, Jinglin Wang, et al.. (2019). Ischemia reperfusion injury promotes recurrence of hepatocellular carcinoma in fatty liver via ALOX12-12HETE-GPR31 signaling axis. Journal of Experimental & Clinical Cancer Research. 38(1). 489–489. 59 indexed citations
16.
Yang, Faji, Longcheng Shang, Shuai Wang, et al.. (2019). TNFα-Mediated Necroptosis Aggravates Ischemia-Reperfusion Injury in the Fatty Liver by Regulating the Inflammatory Response. Oxidative Medicine and Cellular Longevity. 2019. 1–14. 38 indexed citations
17.
Zhou, Yuan, Haozhen Ren, Bo Dai, et al.. (2018). Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts. Journal of Experimental & Clinical Cancer Research. 37(1). 324–324. 370 indexed citations breakdown →
18.
Li, Huihui, Hongting Zhao, Shuangying Hao, et al.. (2018). Iron regulatory protein deficiency compromises mitochondrial function in murine embryonic fibroblasts. Scientific Reports. 8(1). 5118–5118. 33 indexed citations
19.
Yang, Faji, Shuai Wang, Yang Liu, et al.. (2018). IRE1α aggravates ischemia reperfusion injury of fatty liver by regulating phenotypic transformation of kupffer cells. Free Radical Biology and Medicine. 124. 395–407. 38 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mitsuhiko Abe Breakdown of academic impact, for papers by Kate Huang Breakdown of academic impact, for papers by Alexander R. Terry Breakdown of academic impact, for papers by Xing Sun Breakdown of academic impact, for papers by Yuyu Yang Breakdown of academic impact, for papers by Kun Wu Breakdown of academic impact, for papers by Jian Kong Breakdown of academic impact, for papers by Qinyi Zhou Breakdown of academic impact, for papers by Sijun Yang
Rankless by CCL
2026